Winton Group’s BridgeBio Pharma BBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.86M | Buy |
+89,312
| New | +$3.86M | 0.2% | 139 |
|
|
2024
Q4 | – | Sell |
-28,091
| Closed | -$715K | – | 619 |
|
|
2024
Q3 | $715K | Buy |
+28,091
| New | +$715K | 0.05% | 381 |
|
|
2023
Q2 | – | Sell |
-14,312
| Closed | -$237K | – | 787 |
|
|
2023
Q1 | $237K | Buy |
+14,312
| New | +$237K | 0.01% | 866 |
|
|
2022
Q1 | – | Sell |
-13,253
| Closed | -$221K | – | 959 |
|
|
2021
Q4 | $221K | Sell |
13,253
-1,767
| -12% | -$29.5K | 0.01% | 921 |
|
|
2021
Q3 | $704K | Buy |
+15,020
| New | +$704K | 0.04% | 686 |
|